Firefly Neuroscience (AIFF) Equity Income (2023)
Firefly Neuroscience (AIFF) posted Equity Income of -$221653.0 for Q2 2023, down 828.51% on a QoQ basis from -$23872.0 in Q1 2023.
Powered by 
Analysis
Firefly Neuroscience (AIFF) Equity Income (2023) Analysis & Trends
Firefly Neuroscience has reported Equity Income for 1 years, with the latest figure at -$221653.0 in Q2 2023.
- On a quarterly basis, Equity Income changed N/A year-over-year to -$221653.0 in Q2 2023; TTM through Mar 2024 was -$221653.0, a 828.51% decrease from a year earlier, with the FY2023 full-year figure at -$245525.0, changed N/A from the prior year.
- Equity Income was -$221653.0 for Q2 2023 at Firefly Neuroscience, down from -$23872.0 in the prior quarter.
- The five-year high for Equity Income was -$23872.0 in Q1 2023, with the low at -$221653.0 in Q2 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Income (Qtr) |
|---|---|---|---|---|---|
| 1 | GE HealthCare Technologies | 31.10 Bn | 29.22 Bn | 2.18 Bn | - |
| 2 | Lantheus Holdings | 6.59 Bn | 6.00 Bn | 241.86 Mn | - |
| 3 | Heartflow | 4.24 Bn | 3.87 Bn | 53.19 Mn | - |
| 4 | Neogen | 2.58 Bn | 2.39 Bn | 107.80 Mn | - |
| 5 | Butterfly Network | 1.75 Bn | 1.62 Bn | 23.29 Mn | - |
| 6 | QuidelOrtho | 954.15 Mn | 830.75 Mn | - | - |
| 7 | Ceribell | 944.88 Mn | 815.62 Mn | 25.94 Mn | - |
| 8 | Anbio Biotechnology | 941.05 Mn | 929.15 Mn | - | - |
| 9 | Varex Imaging | 780.16 Mn | 694.86 Mn | 76.70 Mn | - |
| 10 | Firefly Neuroscience | 23.25 Mn | 14.03 Mn | 253,000.00 | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2023 | -221,653.00 |
| Mar 31, 2023 | -23,872.00 |